Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?
Venge
P
P
Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
Brattsand
R
R
Laitinen
L A
LA
Persson
C G
CG
D001991:Bronchitis / Q000473:pathology* / Q000628:therapy; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000473:pathology*; D008173:Lung Diseases, Obstructive / Q000473:pathology* / Q000628:therapy